Despite a Delay, We Still Place a 75% Probability on the Syngenta-ChemChina Deal Closing
In addition to releasing third-quarter sales figures that generally matched our expectations, Syngenta admitted on Oct. 25 that ChemChina's deal to purchase Syngenta is unlikely to receive full regulatory approval by the end of 2016, the companies' prior target date. This follows news that European regulators have requested more information from Syngenta and ChemChina related to the deal.As we wrote on Sept. 15, we expected heightened regulatory scrutiny on all the seed and crop chemical deals ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.